Implementing Health Care Reform: Key Provisions Affecting the Pharmaceutical Industry

Foley Hoag LLP
Contact

The Affordable Care Act (also referred to as the “ACA”) was enacted earlier this year culminating over a year of intense political negotiations, legislative drafting, and numerous Congressional hearings over whether, and how, to comprehensively reform the U.S. health care system. The ACA is made up of two pieces of legislation -- the Patient Protection and Affordable Care Act, or “PPACA,” Pub. L. No. 111-148, which President Obama signed on March 23, 2010, and the Health Care and Education Reconciliation Act, or “HCERA,” Pub. L. 111-152, which President Obama signed on March 30, 2010.

This issue of the Health Law Reporter describes some of the sweeping changes the ACA makes to the way in which health care will be accessed, delivered, and paid for in the United States. The ACA has a broad reach, which will affect most Americans, as well as many, if not all, sectors of the U.S. health care system including health care providers, health insurers, and biomedical companies such as pharmaceutical and device manufacturers.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Foley Hoag LLP | Attorney Advertising

Written by:

Foley Hoag LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Foley Hoag LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide